Powered by DataPath
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is the formal name of the coronavirus responsible for the ongoing COVID-19 pandemic. In the United States, since the original outbreak we have so far experienced two variants, Delta and Omicron. Public health experts believe that, like influenza, COVID will eventually become endemic – never completely disappearing, but due to vaccination … More >>
In response to the Delta variant, face masks are once again at the forefront of efforts to prevent further spread of COVID-19. When used for this purpose, they are considered Personal Protective Equipment (PPE), which became a qualified medical expense under Section 213(d) of the Internal Revenue Code in March, 2021. On March 26, the … More >>
The fight against COVID-19 has expanded to the purchase of personal protective equipment (PPE) items with employer-sponsored benefit accounts. On Friday, March 26, the IRS released Announcement 2021-7, which approves PPE purchased for the primary purpose of preventing the spread of COVID-19 as medical expenses under section 213(d) of the Internal Revenue Code. The regulation allows … More >>